Research location
Garches
France
Advertisement
Research activity in Garches
FranceCureCurrent currently publishes aggregate city-level research activity for this location: 48 trials and 49 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Garches
48 linked trials · page 1 of 1EXOPULSE Suit and Walking Ability of Patients With Multiple SclerosisNCT07252895 · 2026-03-30 · 1 site observation
RECRUITING
Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART ControlNCT05300035 · 2024-04-11 · 1 site observation
RECRUITING
French Registry for Monitoring Pregnancies for Multiple SclerosisNCT03900221 · 2019-08-12 · 1 site observation
RECRUITING
CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074)NCT07402044 · 2026-03-15 · 1 site observation
NOT_YET_RECRUITING
Cohort IMEA 070 -Lenacapavir CompassionalNCT06289361 · 2024-04-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 GenotypeNCT05482854 · 2023-03-20 · 1 site observation
UNKNOWN
Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigmaNCT05149001 · 2022-01-17 · 1 site observation
COMPLETED
Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a WeekNCT04867083 · 2021-06-21 · 1 site observation
UNKNOWN
Periodic Leg Movements' Diagnosis in Spinal Cord Injury: Actigraphy as an Alternative for Polysomnography?NCT04618978 · 2021-02-25 · 1 site observation
COMPLETED
Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 InfectionNCT04695379 · 2020-04-27 · 1 site observation
COMPLETED
Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-ageNCT04280367 · 2020-01-28 · 1 site observation
COMPLETED
Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FASTNCT03858478 · 2019-11-18 · 1 site observation
UNKNOWN
Implementation Intention for Physical Activity in Multiple SclerosisNCT03785483 · 2018-12-30 · 1 site observation
UNKNOWN
Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected PatientsNCT03256422 · 2017-09-07 · 1 site observation
COMPLETED
Prevention of HIV in "Île-de-France"NCT03113123 · 2017-05-03 · 1 site observation
UNKNOWN
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2NCT02660359 · 2016-07-08 · 1 site observation
TERMINATED
Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)NCT02429791 · 2015-04-14 · 1 site observation
COMPLETED
Transcutaneous Electrical Nerve Stimulation (TENS) for Lower Urinary Tract Disorders in Parkinson's SyndromeNCT02190851 · 2015-04-01 · 1 site observation
COMPLETED
Screening Strategy for Asymptomatic Sexually Transmitted Infections (STI) in a Cohort of HIV Outpatients Men Who Have Sex With Men (DRIVER)NCT02413632 · 2015-04-01 · 1 site observation
COMPLETED
Physical Capacity and Rehabilitation of Patients With Multiple SclerosisNCT02352194 · 2014-07-01 · 1 site observation
UNKNOWN
4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV PatientsNCT02157311 · 2014-07-01 · 1 site observation
COMPLETED
Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment DisabilitiesNCT01906866 · 2013-10-01 · 1 site observation
COMPLETED
A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected SubjectsNCT01850212 · 2013-02-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)NCT01600716 · 2012-06-13 · 1 site observation
COMPLETED
HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral TherapyNCT04266002 · 2011-11-01 · 1 site observation
COMPLETED
Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple SclerosisNCT01357980 · 2011-05-01 · 1 site observation
COMPLETED
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.NCT01328041 · 2011-05-01 · 1 site observation
COMPLETED
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive AdultsNCT01309243 · 2011-02-01 · 1 site observation
COMPLETED
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive AdultsNCT01231516 · 2010-10-26 · 1 site observation
COMPLETED
A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice DailyNCT01227824 · 2010-10-19 · 1 site observation
COMPLETED
Evaluation of Target Organs Impairment on Patients Suffering From High Blood PressureNCT00925470 · 2009-06-01 · 1 site observation
COMPLETED
National Survey on HypertensionNCT00804167 · 2008-12-01 · 1 site observation
COMPLETED
Prospective Observational Epidemiologic Study of Maraviroc's SafetyNCT00665561 · 2008-03-31 · 1 site observation
COMPLETED
Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple SclerosisNCT00629642 · 2008-03-14 · 1 site observation
COMPLETED
National Survey on Hypertension in Cardiologic Private PracticeNCT00695175 · 2008-02-01 · 1 site observation
COMPLETED
INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.NCT00615134 · 2008-01-01 · 1 site observation
COMPLETED
Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PINCT00517192 · 2007-09-01 · 1 site observation
TERMINATED
Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & EfficacyNCT00615290 · 2007-06-01 · 1 site observation
COMPLETED
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive SubjectsNCT00549198 · 2007-06-01 · 1 site observation
COMPLETED
Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot EvaluationNCT00447902 · 2007-03-01 · 1 site observation
TERMINATED
Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis PatientsNCT00280592 · 2006-01-01 · 2 site observations
COMPLETED
Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected PatientsNCT00140751 · 2005-10-01 · 1 site observation
COMPLETED
Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) InfectionNCT02733419 · 2004-12-01 · 1 site observation
COMPLETED
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV InfectionNCT00062660 · 2003-05-01 · 1 site observation
APPROVED_FOR_MARKETING
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected SubjectsNCT00044577 · 2002-07-16 · 1 site observation
COMPLETED
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral TherapyNCT00004978 · 2000-03-01 · 1 site observation
COMPLETED
Effects of Amlodipine in the Management of Chronic Heart FailureNCT00151619 · 1999-02-10 · 1 site observation
TERMINATED
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive PatientsNCT00002399 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.